Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INGRAPH: Low Grade Systemic Inflammation in Adult Patients With Phenylketonuria
NCT04879277Completed
- Sponsor
- University Hospital Tours
- Start
- May 2021
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by University Hospital Tours. Primary endpoints: Plasma concentrations of pro-inflammatory cytokines and Plasma concentrations of C-reactive protein. Started May 2021; status: completed.
Beyond the preview
Go deeper on NCT04879277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04879277.